SCHEMBL30865637

SCHEMBL30865637

CC(C)c1cnc(C(=O)NCCN(C)C)c2cnc(Cl)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.41
RAD52 P43351 1/20 0.40
CYP1A2 P05177 1/20 0.39
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HRH4 Q9H3N8 2/20 0.38
HRH3 Q9Y5N1 2/20 0.38
WNT1 P04628 1/20 0.37
DYRK1A Q13627 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24810236 1.00 MAPK1 (0.41) MAPK1RAD52CYP1A2HPGDALDH1A1
SCHEMBL30848774 0.81 GABRA1 (0.33) MAPK1ALDH1A1KDM4ELMNAGAA
SCHEMBL30164446 0.80 EGLN1 (0.34) MAPK1SMN1; SMN2TLR8TLR7KDM4E
SCHEMBL24811771 0.80 EGLN1 (0.34) MAPK1SMN1; SMN2TLR8TLR7KDM4E
SCHEMBL30164490 0.77 KDM4E (0.40) RAD52HRH4KDM4EGAA
SCHEMBL24810572 0.77 KDM4E (0.40) RAD52HRH4KDM4EGAA
SCHEMBL24813079 0.76 MEN1 (0.36) MAPK1ALDH1A1SMN1; SMN2KDM4EEGLN1
SCHEMBL30164468 0.76 MEN1 (0.36) MAPK1ALDH1A1SMN1; SMN2KDM4EEGLN1
SCHEMBL24813085 0.75 ADORA2B (0.39)
SCHEMBL30865616 0.75 ADORA2B (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117916232-A Heterocyclic EGFR inhibitors for the treatment of cancer 缆图药品公司 2024-04-19 CN disclosed